107 related articles for article (PubMed ID: 26394987)
21. Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.
Bratoeff E; Segura T; Recillas S; Carrizales E; Palacios A; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):655-62. PubMed ID: 18825535
[TBL] [Abstract][Full Text] [Related]
22. Development of a new gas chromatography-mass spectrometry (GC-MS) methodology for the evaluation of 5α-reductase activity.
Amaral C; Cunha SC; Fernandes JO; Tavares da Silva E; Roleira FM; Teixeira N; Correia-da-Silva G
Talanta; 2013 Mar; 107():154-61. PubMed ID: 23598206
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
24. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
[TBL] [Abstract][Full Text] [Related]
25. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of new pregnane derivatives as 5alpha-reductase inhibitor.
Cabeza M; Heuze I; Bratoeff E; Ramírez E; Martínez R
Chem Pharm Bull (Tokyo); 2001 May; 49(5):525-30. PubMed ID: 11383600
[TBL] [Abstract][Full Text] [Related]
27. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
28. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
29. Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies.
Dhingra R; Malhotra M; Sharma V; Bhardwaj TR; Dhingra N
Curr Top Med Chem; 2018; 18(32):2816-2834. PubMed ID: 30659542
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.
Bratoeff E; Zambrano A; Heuze I; Palacios A; Ramírez D; Cabeza M
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):306-11. PubMed ID: 19874206
[TBL] [Abstract][Full Text] [Related]
31. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
Torres JM; Ruiz E; Ortega E
Prostate; 2003 Jun; 56(1):74-9. PubMed ID: 12746849
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of 3β-substituted amides of 17a-aza-D-homo- 4-androsten-17-one as potent 5α-reductase inhibitors and antimicrobial agents.
Malhotra M; Sharma R; Rawal RK; Heer H; Bhardwaj TR
Curr Top Med Chem; 2013 Aug; 13(16):2047-61. PubMed ID: 23895091
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological evaluation of new progesterone esters as 5alpha-reductase inhibitors.
Ramírez E; Cabeza M; Bratoeff E; Heuze I; Pérez V; Valdez D; Ochoa M; Teran N; Jimenez G; Ramírez T
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1515-8. PubMed ID: 16327180
[TBL] [Abstract][Full Text] [Related]
34. New Potent 5α- Reductase and Aromatase Inhibitors Derived from 1,2,3-Triazole Derivative.
El-Naggar M; El-All ASA; El-Naem SIA; Abdalla MM; Rashdan HRM
Molecules; 2020 Feb; 25(3):. PubMed ID: 32033281
[TBL] [Abstract][Full Text] [Related]
35. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
[TBL] [Abstract][Full Text] [Related]
36. New progesterone esters as 5alpha-reductase inhibitors.
Cabeza M; Heuze I; Bratoeff E; Murillo E; Ramirez E; Lira A
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1081-4. PubMed ID: 11558590
[TBL] [Abstract][Full Text] [Related]
37. 5alpha-reductase isozymes and androgen actions in the prostate.
Zhu YS; Imperato-McGinley JL
Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and bioactivity of new Finasteride conjugate.
Shuang Z; Jiazhen W; Lijuan Y; Zhuo L; Dahai Y; Jinfeng L; Jing Y; Yongtao L; En-Si W; Xuexun F
Bioorg Med Chem Lett; 2011 Jun; 21(11):3439-42. PubMed ID: 21515045
[TBL] [Abstract][Full Text] [Related]
39. Increased muscular dehydroepiandrosterone levels are associated with improved hyperglycemia in obese rats.
Sato K; Iemitsu M; Aizawa K; Mesaki N; Fujita S
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E274-80. PubMed ID: 21285401
[TBL] [Abstract][Full Text] [Related]
40. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
